FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.

2.

Launch of the hereditary cancer clinic for precision oncology at Kokilaben Hospital.

3.

Silibinin is a novel and ancient molecule that highlights the significance of integrated therapies for cancer.

4.

EMA Backs Breast Cancer SERD After FDA No Vote

5.

June 20, 2023, Health Bulletin No. 12.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot